Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Amyloidosis × selinexor × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 44 Leukemia, Myeloid, Acute 25 Recurrence 20 Lymphoma, Large B-Cell, Diffuse 13 Sarcoma 9 Lymphoma 6 Neoplasms, Plasma Cell 5 Neoplasm Metastasis 5 Glioblastoma 5 Endometrial Neoplasms 5 Ovarian Neoplasms 4 Neurofibrosarcoma 4 Neoplasms 4 Melanoma 4 Lymphoma, T-Cell, Peripheral 4 Lymphoma, Non-Hodgkin 4 Colorectal Neoplasms 4 Triple Negative Breast Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Myelodysplastic Syndromes 3 Lymphoma, B-Cell 3 Liposarcoma 3 Glioma 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma 3 Waldenstrom Macroglobulinemia 2 Thymoma 2 Sarcoma, Alveolar Soft Part 2 Rhabdoid Tumor 2 Primary Myelofibrosis 2

Interventions

Dexamethasone 21 Calcium Dobesilate 10 Melphalan 9 Bortezomib 8 Cyclophosphamide 7 Lenalidomide 6 pomalidomide 4 venetoclax 3 miridesap 3 daratumumab 3 ixazomib 2 belantamab mafodotin 2 Thalidomide 2 Doxycycline 2 Biopsy 2 4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene 2 selinexor 1 pegfilgrastim 1 isatuximab 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 carfilzomib 1 birtamimab 1 auricularum 1 Vinorelbine 1 Technetium Tc 99m Pyrophosphate 1 Technetium 1 Tacrolimus 1 Surveys and Questionnaires 1 Pharmaceutical Preparations 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04984330 2022-11-17

STARR

Weill Medical College of Cornell University

Phase EARLY_PHASE1 Withdrawn

Immunoglobulin Light-chain Amyloidosis, Alzheimer Disease, Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡